These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31968208)

  • 1. Immunological axis of berberine in managing inflammation underlying chronic respiratory inflammatory diseases.
    Tew XN; Xin Lau NJ; Chellappan DK; Madheswaran T; Zeeshan F; Tambuwala MM; Aljabali AA; Balusamy SR; Perumalsamy H; Gupta G; Oliver BG; Hsu A; Wark P; Reddy K; Wadhwa R; Hansbro PM; Dua K
    Chem Biol Interact; 2020 Feb; 317():108947. PubMed ID: 31968208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of respiratory syncytial virus replication and virus-induced p38 kinase activity by berberine.
    Shin HB; Choi MS; Yi CM; Lee J; Kim NJ; Inn KS
    Int Immunopharmacol; 2015 Jul; 27(1):65-8. PubMed ID: 25939536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tristetraprolin and its role in regulation of airway inflammation.
    Prabhala P; Ammit AJ
    Mol Pharmacol; 2015 Apr; 87(4):629-38. PubMed ID: 25429052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of anti-inflammatory effects of berberine, and its natural oxidative and reduced derivatives from Rhizoma Coptidis in vitro and in vivo.
    Li CL; Tan LH; Wang YF; Luo CD; Chen HB; Lu Q; Li YC; Yang XB; Chen JN; Liu YH; Xie JH; Su ZR
    Phytomedicine; 2019 Jan; 52():272-283. PubMed ID: 30599908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine improves airway inflammation and inhibits NF-κB signaling pathway in an ovalbumin-induced rat model of asthma.
    Li Z; Zheng J; Zhang N; Li C
    J Asthma; 2016 Dec; 53(10):999-1005. PubMed ID: 27175622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine inhibits lipopolysaccharide-induced expression of inflammatory cytokines by suppressing TLR4-mediated NF-ĸB and MAPK signaling pathways in rumen epithelial cells of Holstein calves.
    Zhao C; Wang Y; Yuan X; Sun G; Shen B; Xu F; Fan G; Jin M; Li X; Liu G
    J Dairy Res; 2019 May; 86(2):171-176. PubMed ID: 31142385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis factor-alpha productions via the inhibition of IkappaB degradation in human lung cells.
    Lee CH; Chen JC; Hsiang CY; Wu SL; Wu HC; Ho TY
    Pharmacol Res; 2007 Sep; 56(3):193-201. PubMed ID: 17681786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine attenuates depressive-like behaviors by suppressing neuro-inflammation in stressed mice.
    Liu YM; Niu L; Wang LL; Bai L; Fang XY; Li YC; Yi LT
    Brain Res Bull; 2017 Sep; 134():220-227. PubMed ID: 28842306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of berberine on interleukin-2 secretion from PHA-treated lymphocytic Jurkat cells.
    Hu S; Chen CW; Chen ST; Tsui KH; Tang TK; Cheng HT; Hwang GS; Yu JW; Li YC; Wang PS; Wang SW
    Int Immunopharmacol; 2019 Jan; 66():267-273. PubMed ID: 30502647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
    Pandey MK; Sung B; Kunnumakkara AB; Sethi G; Chaturvedi MM; Aggarwal BB
    Cancer Res; 2008 Jul; 68(13):5370-9. PubMed ID: 18593939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine and its derivatives represent as the promising therapeutic agents for inflammatory disorders.
    Lu Q; Fu Y; Li H
    Pharmacol Rep; 2022 Apr; 74(2):297-309. PubMed ID: 35083737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of action of naringenin in chronic airway diseases.
    Chin LH; Hon CM; Chellappan DK; Chellian J; Madheswaran T; Zeeshan F; Awasthi R; Aljabali AA; Tambuwala MM; Dureja H; Negi P; Kapoor DN; Goyal R; Paudel KR; Satija S; Gupta G; Hsu A; Wark P; Mehta M; Wadhwa R; Hansbro PM; Dua K
    Eur J Pharmacol; 2020 Jul; 879():173139. PubMed ID: 32343971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory activity of coptisine free base in mice through inhibition of NF-κB and MAPK signaling pathways.
    Chen HB; Luo CD; Liang JL; Zhang ZB; Lin GS; Wu JZ; Li CL; Tan LH; Yang XB; Su ZR; Xie JH; Zeng HF
    Eur J Pharmacol; 2017 Sep; 811():222-231. PubMed ID: 28648405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydroberberine, a hydrogenated derivative of berberine firstly identified in Phellodendri Chinese Cortex, exerts anti-inflammatory effect via dual modulation of NF-κB and MAPK signaling pathways.
    Tan L; Wang Y; Ai G; Luo C; Chen H; Li C; Zeng H; Xie J; Chen J; Su Z
    Int Immunopharmacol; 2019 Oct; 75():105802. PubMed ID: 31401380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine.
    Wang X; Wang N; Li H; Liu M; Cao F; Yu X; Zhang J; Tan Y; Xiang L; Feng Y
    Int J Mol Sci; 2016 Apr; 17(4):577. PubMed ID: 27092498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine suppresses IL-33-induced inflammatory responses in mast cells by inactivating NF-κB and p38 signaling.
    Li W; Yin N; Tao W; Wang Q; Fan H; Wang Z
    Int Immunopharmacol; 2019 Jan; 66():82-90. PubMed ID: 30445310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine suppresses LPS-induced inflammation through modulating Sirt1/NF-κB signaling pathway in RAW264.7 cells.
    Zhang H; Shan Y; Wu Y; Xu C; Yu X; Zhao J; Yan J; Shang W
    Int Immunopharmacol; 2017 Nov; 52():93-100. PubMed ID: 28888780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory and Anti-Inflammatory Effects of Berberine in Lung Tissue and its Potential Application in Prophylaxis and Treatment of COVID-19.
    Majdalawieh AF; Yousef SM; Abu-Yousef IA; Nasrallah GK
    Front Biosci (Landmark Ed); 2022 May; 27(5):166. PubMed ID: 35638433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacological activity of berberine, a review for liver protection.
    Zhou M; Deng Y; Liu M; Liao L; Dai X; Guo C; Zhao X; He L; Peng C; Li Y
    Eur J Pharmacol; 2021 Jan; 890():173655. PubMed ID: 33068590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cholinergic anti-inflammatory pathway: an innovative treatment strategy for respiratory diseases and their comorbidities.
    Yamada M; Ichinose M
    Curr Opin Pharmacol; 2018 Jun; 40():18-25. PubMed ID: 29331768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.